- Have a minimum time on IFN-beta therapy of 48-consecutive weeks prior to Screening. Subjects who switched from one IFN-beta therapy to another in the 48 weeks preceding Screening may be entered into the study if they have been on a stable regimen of their current IFN-beta therapy for a minimum of 3 months prior to Screening